Skip to Main Content

GLP-1 Weight Loss in Chicago

Prescription weight loss solutions

**insurance & self-pay options**


Achieve your weight loss goals with prescription GLP medication and expert guidance from the team of providers at Innovative Care. Choose from three weight loss programs designed to accommodate your individual needs.


Learn More

Frequently Asked Questions

Compounded Semaglutide contains the same primary ingredient as its name-brand, FDA approved counterparts (GLP-1 medications Wegovy, Ozempic), but it is made in a compounding lab.

GLP-1 (glucagon-like peptide-1) receptor agonists are a class of medications that have been approved by the FDA for the treatment of type 2 diabetes and for weight loss. These medications work by mimicking the effects of the hormone GLP-1, which is naturally produced in the body to stimulate insulin secretion and suppress appetite. Some examples of GLP-1 receptor agonists include exenatide (Byetta, Bydureon), liraglutide (Victoza, Saxenda), and semaglutide (Ozempic, Wegovy, Mounjaro). These medications can be administered by injection and may be used in combination with other weight loss medications, such as metformin or a sulfonylurea. It’s important to note that these medications are only available by prescription and should be used under the guidance of a healthcare professional.

GLP-1 (glucagon-like peptide-1) receptors are a type of G protein-coupled receptor (GPCR) found on the surface of cells in the pancreas, brain, and gut. When GLP-1 binds to these receptors, it activates a cascade of intracellular signaling pathways that lead to a number of physiological effects.

In the pancreas, GLP-1 binding to its receptors stimulates the secretion of insulin, which helps to lower blood sugar levels. This effect is particularly important in people with type 2 diabetes, as it can improve glucose control and reduce the risk of complications associated with high blood sugar.

In the brain, GLP-1 binding to its receptors can suppress appetite and reduce food intake, which may contribute to weight loss. This effect is thought to be mediated by GLP-1’s ability to inhibit the activity of hypothalamic neurons that promote hunger and to stimulate the activity of neurons that promote satiety.

In the gut, GLP-1 binding to its receptors can slow down the emptying of the stomach, which can also help to reduce food intake and promote weight loss.

GLP-1 receptor agonists are medications that mimic the effects of GLP-1 by binding to and activating the GLP-1 receptors. These medications can be used to treat type 2 diabetes and as an adjunct therapy for weight loss.

Many insurance companies cover weight loss medication, but it is dependent on the plan and the individual. We offer three different weight loss programs to accommodate patient needs. Our prescription weight loss and Innovative Vitality programs use medical insurance, whereas our compounded Semaglutide weight loss program is designed for individuals who are unable to use medical insurance for weight loss medication.



The cost of weight loss medication and our weight loss program will depend on which option you select. Our prescription weight loss program uses medical insurance, whereas our compounded semaglutide weight loss program is self-pay for $350 per month (includes medication and telemedicine visit). Innovative Vitality is a membership based medical practice with a monthly fee of $250. Patients at Innovative Vitality use their medical insurance for visits and are responsible for any co-pay or deductible amounts in addition to their monthly fee.

Background Image

Access the care you deserve.

Book your appointment today to experience what everyday healthcare should be.

Book My Appointment